Загрузка...
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer
Through the tumor necrosis factor (TNF) receptor type II (TNFR2), TNF preferentially activates, expands, and promotes the phenotypic stability of CD4(+)Foxp3(+) regulatory T (Treg) cells. Those Treg cells that have a high abundance of TNFR2 have the maximal immunosuppressive capacity. We investigate...
Сохранить в:
| Опубликовано в: : | Sci Signal |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8049166/ https://ncbi.nlm.nih.gov/pubmed/29295954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.aan0790 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|